MYB expression was strongly upregulated in the p53-knockout cells compared with p53-wildtype cells, which might explain the multidrug-resistant phenotype of the p53-negative CRC cells and the poor prognosis for CRC with overexpressed MYB[54]. This evidence concerns the gene TP53 and colorectal carcinoma.